BlackRock Investment Management, LLC - JUNIPER PHARMACEUTICALS INC ownership

JUNIPER PHARMACEUTICALS INC's ticker is JNP and the CUSIP is 48203L107. A total of 39 filers reported holding JUNIPER PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of JUNIPER PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$10,0000.0%1,8480.0%0.00%
Q3 2016$10,000
-23.1%
1,8480.0%0.00%
Q2 2016$13,000
+8.3%
1,8480.0%0.00%
Q1 2016$12,000
-36.8%
1,8480.0%0.00%
Q4 2015$19,000
-9.5%
1,848
+3.4%
0.00%
Q3 2015$21,000
+31.2%
1,7880.0%0.00%
Q2 2015$16,0001,7880.00%
Other shareholders
JUNIPER PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
JW Asset Management, LLC 328,133$1,838,0001.22%
Stonepine Capital Management, LLC 228,392$1,279,0000.76%
Krensavage Asset Management, LLC 290,853$1,629,0000.58%
ALGERT GLOBAL LLC 84,045$471,0000.14%
HEARTLAND ADVISORS INC 400,000$2,240,0000.12%
TFS CAPITAL LLC 16,912$95,0000.02%
Spark Investment Management LLC 50,500$282,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 180,200$1,009,0000.01%
GSA CAPITAL PARTNERS LLP 20,792$116,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 24,390$137,0000.00%
View complete list of JUNIPER PHARMACEUTICALS INC shareholders